ST Pharm Co.,Ltd. (237690.KQ)

KRW 77400.0

(0.91%)

Eps Summary of ST Pharm Co.,Ltd.

ST Pharm Co.,Ltd.'s latest annual eps in 2023 was 1041.07 KRW , up 8.78% from previous year.
ST Pharm Co.,Ltd.'s latest quarterly eps in 2024 Q2 was 48.06 KRW , down -85.5% from previous quarter.
ST Pharm Co.,Ltd. reported an annual eps of 957.00 KRW in 2022, up 439.15% from previous year.
ST Pharm Co.,Ltd. reported an annual eps of 177.50 KRW in 2021, up 127.26% from previous year.
ST Pharm Co.,Ltd. reported a quarterly eps of 48.06 KRW for 2024 Q2, down -85.5% from previous quarter.
ST Pharm Co.,Ltd. reported a quarterly eps of 545.08 KRW for 2024 Q3, up 1034.17% from previous quarter.

Annual Eps Chart of ST Pharm Co.,Ltd. (2023 - 2015)

Historical Annual Eps of ST Pharm Co.,Ltd. (2023 - 2015)

Year	Eps	Eps Growth
2023	1041.07 KRW	8.78%
2022	957.00 KRW	439.15%
2021	177.50 KRW	127.26%
2020	-651.11 KRW	34.44%
2019	-993.18 KRW	-99.92%
2018	-496.78 KRW	-120.52%
2017	2421.53 KRW	-37.28%
2016	3861.10 KRW	92.0%
2015	2011.00 KRW	0.0%

Year	Eps	Eps Growth
2024 Q1	331.45 KRW	-40.8%
2024 Q2	48.06 KRW	-85.5%
2024 Q3	545.08 KRW	1034.17%
2023 Q2	70.80 KRW	-64.85%
2023 Q3	208.98 KRW	195.17%
2023 Q4	559.87 KRW	167.91%
2023 FY	- KRW	8.78%
2023 Q1	201.42 KRW	51.93%
2022 Q1	101.38 KRW	142.13%
2022 Q4	132.57 KRW	-75.55%
2022 FY	- KRW	439.15%
2022 Q3	542.11 KRW	199.61%
2022 Q2	180.94 KRW	78.48%
2021 Q4	-240.63 KRW	-159.85%
2021 FY	- KRW	127.26%
2021 Q3	402.05 KRW	39.95%
2021 Q2	287.28 KRW	207.6%
2021 Q1	-266.98 KRW	-24.72%
2020 Q2	155.76 KRW	170.0%
2020 Q3	-374.00 KRW	-340.11%
2020 Q4	-214.06 KRW	42.76%
2020 FY	- KRW	34.44%
2020 Q1	-222.53 KRW	57.02%
2019 Q4	-517.74 KRW	-895.65%
2019 Q2	-142.43 KRW	49.44%
2019 Q1	-281.69 KRW	35.38%
2019 FY	- KRW	-99.92%
2019 Q3	-52.00 KRW	63.49%
2018 Q1	42.69 KRW	-89.51%
2018 Q3	-357.00 KRW	-231.25%
2018 FY	- KRW	-120.52%
2018 Q2	271.99 KRW	537.13%
2018 Q4	-435.91 KRW	-22.1%
2017 Q4	407.15 KRW	-3.75%
2017 Q3	423.00 KRW	-51.22%
2017 FY	- KRW	-37.28%
2017 Q2	867.13 KRW	20.1%
2017 Q1	722.02 KRW	13.82%
2016 Q4	634.33 KRW	-27.51%
2016 Q2	1639.94 KRW	133.79%
2016 FY	- KRW	92.0%
2016 Q1	701.46 KRW	4.3%
2016 Q3	875.00 KRW	-46.64%
2015 Q3	924.00 KRW	217.53%
2015 Q4	672.57 KRW	-27.21%
2015 Q2	291.00 KRW	0.0%
2015 FY	- KRW	0.0%

Peer Eps Comparison of ST Pharm Co.,Ltd.

Name	Eps	Eps Difference
Sam Chun Dang Pharm. Co., Ltd	-463.03 KRW	324.839%
Hyundai Bioscience Co., Ltd.	-365.00 KRW	385.225%
ABL Bio Inc.	-55.32 KRW	1981.905%
Cellid, Co., Ltd.	-1078.05 KRW	196.57%